Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4466721
Max Phase: Preclinical
Molecular Formula: C26H20F2N4
Molecular Weight: 426.47
Molecule Type: Unknown
Associated Items:
ID: ALA4466721
Max Phase: Preclinical
Molecular Formula: C26H20F2N4
Molecular Weight: 426.47
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Fc1ccccc1N/N=C/c1ccc(-c2ccc(/C=N/Nc3ccccc3F)cc2)cc1
Standard InChI: InChI=1S/C26H20F2N4/c27-23-5-1-3-7-25(23)31-29-17-19-9-13-21(14-10-19)22-15-11-20(12-16-22)18-30-32-26-8-4-2-6-24(26)28/h1-18,31-32H/b29-17+,30-18+
Standard InChI Key: RRKCLLFZROAJHM-YAGSLNJISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 426.47 | Molecular Weight (Monoisotopic): 426.1656 | AlogP: 6.52 | #Rotatable Bonds: 7 |
Polar Surface Area: 48.78 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 5.22 | CX LogP: 7.56 | CX LogD: 7.56 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.26 | Np Likeness Score: -0.97 |
1. Thamban Chandrika N, Dennis EK, Shrestha SK, Ngo HX, Green KD, Kwiatkowski S, Deaciuc AG, Dwoskin LP, Watt DS, Garneau-Tsodikova S.. (2019) N,N'-diaryl-bishydrazones in a biphenyl platform: Broad spectrum antifungal agents., 164 [PMID:30597328] [10.1016/j.ejmech.2018.12.042] |
Source(1):